Want to see FR:EAPI full AI Analyst Report?

Euroapi SA (EAPI) Price & Analysis

11 Followers

EAPI Stock Chart & Stats

€0.92

€0.02(1.30%)

At close: Jul 27 4:00 PM EDT

€0.92

€0.02(1.30%)

Day’s Range― - ―

52-Week Range€0.71 - €3.39

Previous CloseN/A

Volume87.98K

Average Volume (3M)200.45K

Market Cap

€76.97M

Enterprise Value€383.33M

Total Cash (Recent Filing)€52.00M

Total Debt (Recent Filing)€309.00M

Price to Earnings (P/E)―

Beta1.55

Next Earnings

Mar 09, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-3.42

Shares Outstanding96,010,155

10 Day Avg. Volume198,743

30 Day Avg. Volume200,454

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)0.27

Price to Sales (P/S)0.25

P/FCF Ratio4.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-1.04

Revenue Forecast (FY)€748.26M

Bulls Say, Bears Say

Bulls Say

Conservative LeverageVery low leverage gives Euroapi financial flexibility while it works through operating challenges. A limited debt burden can reduce refinancing and interest pressure, preserve capacity for investment in API manufacturing, and provide a stronger buffer against volatility than a highly indebted balance sheet.

Improved Cash GenerationPositive operating and free cash flow in the latest two years indicates that the business has recently converted operations into cash despite reported losses. If maintained, this can support investment, working-capital needs, and financial resilience without relying heavily on additional borrowing.

Embedded API Supplier ModelEuroapi serves an essential point in the medicine-production chain, combining commercial API manufacturing with development and industrialization services. This business-to-business positioning can support recurring customer relationships and broaden engagement as molecules progress toward commercial production.

Bears Say

Declining RevenueRepeated revenue declines indicate that demand, volumes, or customer activity have not yet produced a stable growth trajectory. Continued top-line weakness can reduce capacity utilization, limit operating leverage, and make it harder for Euroapi to absorb fixed manufacturing and development costs.

Deepening Net LossesPersistent and widening net losses show that improved EBITDA has not translated into sustainable bottom-line profitability. This weakens internal capital generation, reduces shareholder returns, and leaves the company more exposed to non-operating costs or charges that could continue weighing on earnings.

Volatile Earnings QualityThe gap between positive recent cash flow and deeply negative net income, together with prior years of negative free cash flow, points to uneven earnings quality and cash conversion. Such volatility complicates planning and raises the risk that recent cash generation may not represent a stable long-term pattern.

Euroapi SA News

Euroapi Publishes 2026 Half-Year Financial Report

Euroapi SA ( ($FR:EAPI) ) has shared an update. Euroapi SA has published its condensed half-year consolidated financial...

3M ago

Euroapi’s H1 2026 Loss Deepens as FOCUS‑27 Restructuring and Site Sale Weigh on Earnings

Euroapi SA ( ($FR:EAPI) ) has provided an announcement. Euroapi SA reported first‑half 2026 revenue of €356.5 million,...

3M ago

EAPI FAQ

What was Euroapi SA’s price range in the past 12 months?

Euroapi SA lowest stock price was €0.71 and its highest was €3.39 in the past 12 months.

What is Euroapi SA’s market cap?

Euroapi SA’s market cap is €76.97M.

When is Euroapi SA’s upcoming earnings report date?

Euroapi SA’s upcoming earnings report date is Mar 09, 2027 which is in 130 days.

How were Euroapi SA’s earnings last quarter?

Euroapi SA released its earnings results on Jul 29, 2026. The company reported -€1.494 earnings per share for the quarter.

Is Euroapi SA overvalued?

According to Wall Street analysts Euroapi SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Euroapi SA pay dividends?

Euroapi SA does not currently pay dividends.

What is Euroapi SA’s EPS estimate?

Euroapi SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Euroapi SA have?

Euroapi SA has 96,010,155 shares outstanding.

What happened to Euroapi SA’s price movement after its last earnings report?

Euroapi SA reported an EPS of -€1.494 in its last earnings report. Following the earnings report the stock price went up 1.774%.

Which hedge fund is a major shareholder of Euroapi SA?

Currently, no hedge funds are holding shares in FR:EAPI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Euroapi SA

Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.